Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach. | In Silico Pharmacol | 2024 | 38721057 | PubTator, text mining | PubMed |
| Accuracy and efficiency stereo matching network with adaptive feature modulation. | PLoS One | 2024 | 38662662 | PubTator, text mining | PubMed |
| Enhancing Error Detection on Medical Knowledge Graphs via Intrinsic Label. | Bioengineering (Basel) | 2024 | 38534499 | PubTator, text mining | PubMed |
| Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours. | Basic Clin Pharmacol Toxicol | 2024 | 38501576 | PubTator, text mining | PubMed |
| Graph Attention Network and Informer for Multivariate Time Series Anomaly Detection. | Sensors (Basel) | 2024 | 38475058 | PubTator, text mining | PubMed |
| FHND004 inhibits malignant proliferation of multiple myeloma by targeting PDZ-binding kinase in MAPK pathway. | Aging (Albany NY) | 2024 | 38460944 | PubTator, text mining | PubMed |
| The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells. | Cancer Immunol Res | 2024 | 38407902 | PubTator, text mining | PubMed |
| Identification and validation of a novel 9-gene signature of non-specific classification to predict prognosis in glioma patients. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38372105 | PubTator, text mining | PubMed |
| Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis. | Sci Rep | 2024 | 38307969 | PubTator, text mining | PubMed |
| A Cross-Sectional Study of Alzheimer-Related Proteins in Women with Polycystic Ovary Syndrome. | Int J Mol Sci | 2024 | 38256230 | PubTator, text mining | PubMed |
| p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy. | Cancers (Basel) | 2024 | 38254747 | PubTator, text mining | PubMed |
| Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes. | Sci Rep | 2024 | 38238555 | PubTator, text mining | PubMed |
| Sox9 regulates alternative splicing and pancreatic beta cell function. | Nat Commun | 2024 | 38238288 | PubTator, text mining | PubMed |
| Bruceine D and Narclasine inhibit the proliferation of breast cancer cells and the prediction of potential drug targets. | PLoS One | 2024 | 38215156 | PubTator, text mining | PubMed |
| Cleavage of cell junction proteins as a host invasion strategy in leptospirosis. | Appl Microbiol Biotechnol | 2024 | 38204132 | PubTator, text mining | PubMed |
| Exploring the role of PRDX4 in the development of uterine corpus endometrial carcinoma. | Med Oncol | 2024 | 38177789 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors. | Genome Med | 2024 | 38167466 | PubTator, text mining | PubMed |
| RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness. | BMC Cancer | 2024 | 38167018 | PubTator, text mining | PubMed |
| TOPK promotes the development of psoriasis and worenine alleviates psoriasiform dermatitis by inhibiting TOPK activity. | J Eur Acad Dermatol Venereol | 2024 | 38131517 | PubTator, text mining | PubMed |
| Proton pump inhibitors and risk of gastrointestinal cancer: A meta‑analysis of cohort studies. | Oncol Lett | 2024 | 38073768 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=7